Advertisement Battelle acquires Instem Provantis, submit preclinical softwares - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Battelle acquires Instem Provantis, submit preclinical softwares

R&D firm Battelle has acquired Instem's two preclinical software applications - Provantis and submit - to automate processes within its GLP compliant preclinical facilities.

Provantis is a modern, fully integrated Windows-based system for organizations and universities engaged in non-clinical evaluation studies.

The submit solution suite converts data from any source system into Standard for Exchange of Nonclinical Data (SEND) files and allows sponsors, CRO’s and regulators to share, visualize and analyze study data efficiently.

Instem North American Sales VP John Anderson-Carter said knowing the active role Battelle plays in conducting studies for a variety of clients, they are honored to welcome them as a new client.